CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies

Name: CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies
License: Public Domain

Wuhan Sian Medical Technology Co., Ltd

ClinicalTrials.gov · Datasets · License: Public Domain

acute lymphoblastic leukemia, b cell lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 481758
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.